Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Friday, February 28, 2014
Louisiana Board of Pharmacy Publishes Second Draft of Regulations Relating to office use or non patient specific compounds; new term is "pharmacy-generated drug"
2014-C ~ Amends Chapter 25 of the Board's rules, more specifically Subchapter C - Compounding of Drugs. Act 168 of the 2013 Legislature introduced a new term "pharmacy-generated drug" to describe a drug made by a pharmacy in response to a non patient-specific order. Compounding is used to describe the process whereby a pharmacy makes a drug in response to a patient-specific order. In addition to incorporating the new legislatively-defined term, the proposal also retains the basic elements of the currently-pending emergency rule and also incorporates suggestions and comments offered during public hearings on the emergency rule. 11-13-2013 - Committee reviewed Draft #1 and requested further changes and discussion. 02-06-2014 - Committee discussed further changes and requested new draft; Draft #2 prepared. 02-25-2014 - Draft #2 scheduled for review by the committee.